Advanced search
Search Results: 59 results for keyword "SK Group".
SK ecoplant and Nami Solar launch joint venture to invest in Vietnam’s distributed solar sector
25-01-2022 17:35
SK Group has further expanded its investment in Vietnam through a new partnership between its green investment arm, SK ecoplant, and Nami Solar, an affiliate of Nami Energy.
HCM City to complete COVID-19 vaccination for risk group by Jan. 20
13-01-2022 16:37
Ho Chi Minh City plans to complete the vaccination of people at risk from COVID-19 by January 20 while pressing on with rapid testing for this group.
Masan’s masterplan to lure investors
09-12-2021 08:00
The establishment of The CrownX opens the first chapter of Masan’s Point of Life strategy, which aims to serve essential products and services on an integrated offline-to-online platform.
Pharma giants beat revenue expectations
25-11-2021 12:13
Pharmaceutical companies like Pfizer, Novartis, Roche, and GSK performed well in the first three quarters of 2021, with plans to venture further into the lucrative Vietnamese market.
Stable figures for M&A as groups rebuild
18-11-2021 12:17
Dealmaking in Vietnam is showing signs of recovery after a subdued year, and domestic figures are even surpassing pre-pandemic levels.
SK Group to spend $340 million to increase stake in Masan's retail arm
11-11-2021 18:59
SK Group will spend $340 million acquiring shares of The CrownX (TCX) under Masan Group to double down on the latter's Point of Life (POL) strategy.
International investors scoop up major stakes in drugmakers
30-06-2021 14:20
Dealmaking and investment in pharmaceutical and healthcare businesses are increasing in scope as investors are vying for the controlling stake of key players.
SK Group donates $1 million to Vietnam’s vaccine fund
25-06-2021 15:47
Koh Jong Hwan, the Hanoi representative of SK Group, today handed over a donation of $1 million for Vietnam’s national COVID-19 Vaccine Fund in order to support the procurement, vaccination, research and development, and production of domestic vaccines. The hand-over ceremony was held at the Ministry of Health under the witness of Minister Nguyen Thanh Long and Korean Ambassador Park Noh-wan.
Foreign investors maintain interest in Vietnam
07-05-2021 16:43
Despite a year-on-year slip in foreign direct investment (FDI) to Vietnam in the first four months of the year, foreign investors still signed major deals in the country and confirmed its ongoing investment appeal.
Hydrogen fuel cell maker Plug Power to expand operations with SK Group
05-05-2021 17:54
Hydrogen fuel cell maker Plug Power, the leading provider of comprehensive hydrogen fuel cell turnkey solutions, is signalling interest in potential markets, including Vietnam, South Korea, and China through a joint venture with SK Group.
South Korean investors back from recess
22-04-2021 10:00
The South Korean investment landscape in Vietnam is brightening up, following new investments worth billions of dollars, with SK and Hanwha pouring a great deal into their projects.
M&A on cusp of post-COVID-19 surge
20-04-2021 20:00
As global mergers and acquisitions activity continues to rebound following a pandemic-fuelled freeze, Vietnam is expected to benefit from the growth of deal-making.
Robust growth trends projected for investment in healthcare
09-04-2021 10:00
Vietnam’s healthcare and pharmacy chains are increasingly getting new funds to expand their operations in local market, thereby securing access and availability of medical supplies and drugs for locals. However, concerns over adequate human resources in the sector dampen the bright prospects and could cause supply issues.
SK Group to acquire 16.26 per cent stake in VinCommerce
06-04-2021 12:12
Masan Group Corporation and SK Group today announced the signing of definitive agreements for SK’s acquisition of a 16.26 per cent stake in VinCommerce (VCM) for a total cash consideration of $410 million. The transaction values VCM at $2.5 billion.
New M&As in healthcare can evade pandemic uncertainties
20-11-2020 20:59
Mergers and acquisitions in Vietnam’s healthcare and pharmaceutical sector in 2020 have been held up due to the global health crisis – but prospects remaining enticing thanks to new drivers of interest.
Mobile Version